Source: Eur Respir J 2010; 36: 720-721



Rating:

Share or cite this content

Citations should be made in the following way:
Cerveri I., De Marco R.. What makes large epidemiological studies comparable?. Eur Respir J 2010; 36: 720-721

Member's Comments

No comment yet.

Related content which might interest you: How to define asthma in large-scale studies? Source: International Congress 2014 – Is asthma prevalence still increasing? Year: 2014 What can we learn from large scale COPD studies? Source: Annual Congress 2013 –ME6 What can we learn from large scale COPD studies? Year: 2013 Can epidemiological studies determine the productivity-related burden of COPD? Source: Eur Respir J, 50 (3) 1701515; 10.1183/13993003.01515-2017 Year: 2017 What type of clinical evidence is needed to assess medical devices? Source: Eur Respir Rev 2016; 25: 259-265 Year: 2016 Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 What can we learn from paediatric cohort studies? Source: International Congress 2018 – Paediatric Year in Review Year: 2018 Utilising data from single cell approaches to study existing and recently emerging lung diseases? Source: Virtual Congress 2021 – Utilising data from single cell approaches to study existing and recently emerging lung diseases? Year: 2021 Implications of the exposome and its applicability in clinical and epidemiological studies Source: International Congress 2016 – Genetics, epigenetics and the exposome Year: 2016 Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 How to translate findings from experimental models into clinical studies in OSA Source: Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases Year: 2019 Do we have enough evidence overall, or should we wait for ongoing trials? Source: International Congress 2014 – From respiratory infections to wheezing: reevaluating the role of vitamin D levels in childhood Year: 2014 Overview on observational studies Source: ERS Course 2015 Year: 2015 Evidence provided by recent meta-analyses on treatment: what is new? Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET) Year: 2012 What requirements should a biomarker meet to be used in the clinical and epidemiological setting? Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008 What have we learn from rebiospy studies? Source: ERS Research Seminar Year: 2015 ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies Source: Virtual Congress 2020 – New developments in pandemic medicine Year: 2020 Impact of clinical and socio-economic factors on tuberculosis transmission rate in European cities: meta-analysis of molecular epidemiological studies Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009